196 related articles for article (PubMed ID: 2476814)
1. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
[TBL] [Abstract][Full Text] [Related]
2. Cordycepin analogues of 2',5'-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase.
Müller WE; Weiler BE; Charubala R; Pfleiderer W; Leserman L; Sobol RW; Suhadolnik RJ; Schröder HC
Biochemistry; 1991 Feb; 30(8):2027-33. PubMed ID: 1705437
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates.
Sobol RW; Fisher WL; Reichenbach NL; Kumar A; Beard WA; Wilson SH; Charubala R; Pfleiderer W; Suhadolnik RJ
Biochemistry; 1993 Nov; 32(45):12112-8. PubMed ID: 7692966
[TBL] [Abstract][Full Text] [Related]
4. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.
Karikó K; Sobol RW; Suhadolnik L; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W
Biochemistry; 1987 Nov; 26(22):7127-35. PubMed ID: 3427062
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2',5'-oligoadenylate derivatives.
Sobol RW; Henderson EE; Kon N; Shao J; Hitzges P; Mordechai E; Reichenbach NL; Charubala R; Schirmeister H; Pfleiderer W
J Biol Chem; 1995 Mar; 270(11):5963-78. PubMed ID: 7890727
[TBL] [Abstract][Full Text] [Related]
6. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection.
Schröder HC; Suhadolnik RJ; Pfleiderer W; Charubala R; Müller WE
Int J Biochem; 1992; 24(1):55-63. PubMed ID: 1374726
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B).
Homan JW; Steele AD; Martinand-Mari C; Rogers TJ; Henderson EE; Charubala R; Pfleiderer W; Reichenbach NL; Suhadolnik RJ
J Acquir Immune Defic Syndr; 2002 May; 30(1):9-20. PubMed ID: 12048358
[TBL] [Abstract][Full Text] [Related]
8. Phosphorothioate analogues of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates.
Karikó K; Li SW; Sobol RW; Suhadolnik RJ; Charubala R; Pfleiderer W
Biochemistry; 1987 Nov; 26(22):7136-42. PubMed ID: 3427063
[TBL] [Abstract][Full Text] [Related]
9. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatic synthesis, properties, and biological activities of 2',5'-phosphorothioates from adenosine 5'-O-(2-thiotriphosphate) and adenosine 5'-O-(3-thiotriphosphate).
Suhadolnik RJ; Lee C; Karikó K; Li SW
Biochemistry; 1987 Nov; 26(22):7143-9. PubMed ID: 3427064
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).
Dimitrova DI; Reichenbach NL; Yang X; Pfleiderer W; Charubala R; Gaughan JP; Suh B; Henderson EE; Suhadolnik RJ; Rogers TJ
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):123-34. PubMed ID: 17263642
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
Matsukura M; Zon G; Shinozuka K; Stein CA; Mitsuya H; Cohen JS; Broder S
Gene; 1988 Dec; 72(1-2):343-7. PubMed ID: 3243433
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.
Schröder HC; Kelve M; Schäcke H; Pfleiderer W; Charubala R; Suhadolnik RJ; Müller WE
Chem Biol Interact; 1994 Feb; 90(2):169-83. PubMed ID: 8156606
[TBL] [Abstract][Full Text] [Related]
13. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.
Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623
[TBL] [Abstract][Full Text] [Related]
16. The 2-5A system and HIV infection.
Schröder HC; Kelve M; Müller WE
Prog Mol Subcell Biol; 1994; 14():176-97. PubMed ID: 7914804
[TBL] [Abstract][Full Text] [Related]
17. Characterization and biological activity of 8-substituted analogues of 2',5'-oligoadenylates.
Nagai K; Kanbara K; Nakashima H; Yamamoto N; Suhadolnik RJ; Takaku H
Biochim Biophys Acta; 1993 Mar; 1156(3):321-6. PubMed ID: 8461324
[TBL] [Abstract][Full Text] [Related]
18. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
[TBL] [Abstract][Full Text] [Related]
19. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
[TBL] [Abstract][Full Text] [Related]
20. Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.
Player MR; Maitra RK; Silverman RH; Torrence PF
Antivir Chem Chemother; 1998 May; 9(3):225-31. PubMed ID: 9875401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
